Feasibility of Early Gabapentin as an Intervention for Neurorecovery
Status:
Recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
The objective of the proposed study is to conduct the first ever prospective,
dose-exploration trial to test the feasibility of early administration of gabapentin as an
intervention for neurorecovery. This research project falls under the Intervention
Development stage of research as the primary goal is to assess the feasibility of conducting
a well-designed intervention efficacy study in the future.
Phase:
Phase 4
Details
Lead Sponsor:
MetroHealth Medical Center
Collaborator:
National Institute on Disability, Independent Living, and Rehabilitation Research